Cargando…
Differential cytotoxicity induced by the Titanium(IV)Salan complex Tc52 in G2-phase independent of DNA damage
BACKGROUND: Chemotherapy is one of the major treatment modalities for cancer. Metal-based compounds such as derivatives of cisplatin are in the front line of therapy against a subset of cancers, but their use is restricted by severe side-effects and the induction of resistance in treated tumors. Sub...
Autores principales: | Pesch, Theresa, Schuhwerk, Harald, Wyrsch, Philippe, Immel, Timo, Dirks, Wilhelm, Bürkle, Alexander, Huhn, Thomas, Beneke, Sascha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944496/ https://www.ncbi.nlm.nih.gov/pubmed/27412346 http://dx.doi.org/10.1186/s12885-016-2538-0 |
Ejemplares similares
-
Titanium Salan Complexes Displays Strong Antitumor Properties In Vitro and In Vivo in Mice
por: Immel, Timo A., et al.
Publicado: (2011) -
Cytosolic Ca(2+) shifts as early markers of cytotoxicity
por: Wyrsch, Philippe, et al.
Publicado: (2013) -
Synthesis and Application of New Salan Titanium Complexes in the Catalytic Reduction of Aldehydes
por: Hipólito, Joana, et al.
Publicado: (2022) -
Octahedral
Zirconium Salan Catalysts for Olefin Polymerization:
Substituent and Solvent Effects on Structure and Dynamics
por: Dall’Anese, Anna, et al.
Publicado: (2023) -
A Single-Site Iron(III)-Salan Catalyst for Converting COS to Sulfur-Containing Polymers
por: Gu, Ge-Ge, et al.
Publicado: (2017)